The U.S. Food and Drug Administration (FDA) recently issued a warning statement about the drug Gilenya, used to treat multiple sclerosis. The troubling reports about patients who stopped using the medication indicated that cessation of use can lead to significant and severe worsening of disabilities caused by the disease. Some patients even experienced a complete […]